Traditionally, an insulin bolus has been administered to overcome the insulin resistance seen during a hyperglycemic crisis, but in more recent years this practice has come into question, given the concern for hypokalemia and hypoglycemia [6,7,8]. The gene discussed is INS; the disease is Hypoglycemia.